InvestorsHub Logo
Followers 14
Posts 641
Boards Moderated 0
Alias Born 02/20/2014

Re: None

Friday, 01/06/2017 6:32:55 AM

Friday, January 06, 2017 6:32:55 AM

Post# of 22929
anticipate accelerated sales throughout 2017

"Michael Gelmon, CEO of Axxess Pharma, Inc. stated, "The CoreX line is anticipated to generate strong revenues for our company, throughout North America. We have already talked with several of our national wholesalers and retailers and anticipate accelerated sales throughout 2017."